Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Drug Detection Trends in Umbilical Cord and Meconium and the Impact of Enzymatic Hydrolysis in Cord Analysis

SOFT-THIAFT 2026

Joint meeting between Society of Forensic Toxicologists and The International Association of Forensic Toxicologists

Chicago, IL, Sep 19-24, 2026

Poster presentation: Drug Detection Trends in Umbilical Cord and Meconium and the Impact of Enzymatic Hydrolysis in Cord Analysis

(abstract can be found on page 775 in abstract book: link above)

Authors: Evans T, Dui W, Skirnick O, Smith MP, Bartock SH

Medical Specialty: Prescription drug monitoring, Toxicology, Women's health, OB/GYN, Pediatrics

Related content

Conference Presentation
Meconium Marijuana Trends: Prevalence of Delta8-THCCOOH
Publication
Δ8-Tetrahydrocannabinol, Δ9-Tetrahydrocannabinol, and Cannabidiol Carboxylic Acid Metabolites in Authentic Meconium Samples
Conference Presentation
Analysis of Δ8-Tetrahydrocannabinol, Δ9-Tetrahydrocannabinol, and Cannabidiol Metabolites in Authentic Meconium Samples
Audio Podcast
Drug Testing for Stimulants
Conference Presentation
Development of a Semi-Quantitative Liquid Chromatography Tandem Mass Spectrometry Method for 62 Drugs in Umbilical Cord Tissue

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.